Goshen News 1 month ago

FDA panel rejects Zimmer spine implant

GAITHERSBURG, Md. — Federal health advisers on Wednesday rejected an implant from Zimmer Holdings saying it’s unclear how effective or safe the device would be for treating a painful spinal condition. Full Article at Goshen News

Related Topics:

  1. US Food and Drug Administration
  2. Food and Drug Administration
  3. University of Pennsylvania

Related Articles

  1. FDA panel has questions about Zimmer spine implant
    1 month ago

    GAITHERSBURG, Md. (AP) - Federal health officials say there are lingering questions about whether an implant from Zimmer Holdings Inc. is safe and effective for treating a painful spinal condition. Full Article at WCAX

  2. Indianapolis Star logo
    FDA questions role of payments in Zimmer study
    1 month ago

    WASHINGTON -- Federal health officials say an implant from Zimmer Holdings Inc. appears to be effective in treating spinal problems, but questions remain about whether company payments to doctors influenced the device's trial data. Full Article at Indianapolis Star

Related Quotes

There are no results for this module. Edi the module to change the search term used to query related quotes.

(What's this?)
  1. Are you a Publisher?

    We built Daylife.com using our SmartMedia Services platform, which can give you thousands of content-rich, advertiser-friendly pages (like this one) on any topic and with full editorial control. Learn More »

    Our Customers
    prev
    next
  2. Our Products
    Daylife Select

    A point & click tool to create dynamic content portals. Learn More »

  3. Daylife API

    Unlimited smart, customizable content to suit any publisher. Learn More »

  4. Enterprise API

    Use the Daylife Platform to distribute content across your sites. Learn More »

  5. SmartContext

    Weave the web's best content into your own. Learn More »

Browse More Photos

Daylife is the web's largest archive of news photos

  1. St. Jude Medical, Inc. today announced the U.S. Food and Drug Administration (FDA) approval and U.S. market introduction of its new Penta(TM) surgical lead for neurostimulation therapy.
  2. WASHINGTON - JUNE 12: University of Florida's Emerging Pathogens Institute Director Glenn Morris testifies before the House Subcommittee on Oversight and Investigations June 12, 2008 in Washington, DC.
  3. WASHINGTON - APRIL 22: Commissioner of the Food and Drug Administration Andrew von Eschenbach testifies during a hearing before the Subcommittee on Oversight and Investigations of the House Energy & Commerce Committee April 22, 2008 on Capitol Hill in Washington, DC.

Cast of Characters

  1. US Food and Drug Administration US Food and Drug Administration
  2. Food and Drug Administration Food and Drug Administration
  3. University of Pennsylvania University of Pennsylvania
  4. University of Florida
  5. NYSE NYSE
  6. Medtronic, Inc. Medtronic, Inc.